Skip to main content
. 2020 Dec 16;10(12):1098. doi: 10.3390/diagnostics10121098

Figure 3.

Figure 3

Forest plot of the (A) grade 3 or 4 adverse event rates and (B) grade 3 or 4 CNS-related adverse event rates when using immune checkpoint inhibitor (ICI) monotherapy, ICI combined with chemotherapy, and ICI combined with radiotherapy.